Ganglioside GM2, highly expressed in the MIA PaCa-2 pancreatic ductal adenocarcinoma cell line, is correlated with growth, invasion, and advanced stage

[1]  M. Toyoda,et al.  Fetal bovine serum enlarges the size of human pancreatic cancer spheres accompanied by an increase in the expression of cancer stem cell markers. , 2019, Biochemical and biophysical research communications.

[2]  M. Toyoda,et al.  Comparison of functional glycans between cancer stem cells and normal stem cells. , 2019, Histology and histopathology.

[3]  M. Toyoda,et al.  Gangliosides Contribute to Vascular Insulin Resistance , 2019, International journal of molecular sciences.

[4]  M. Toyoda,et al.  H19 long non-coding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells , 2018, Oncotarget.

[5]  T. Ishiwata,et al.  Pancreatic cancer stem cells: features and detection methods , 2018, Pathology & Oncology Research.

[6]  Hua Yu,et al.  Erratum: JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance (Cell Metabolism (2018) 27(1) (136–150.e5)(S1550413117306691)(10.1016/j.cmet.2017.11.001)) , 2018 .

[7]  M. Michishita,et al.  Reduced expression of the H19 long non-coding RNA inhibits pancreatic cancer metastasis , 2018, Laboratory Investigation.

[8]  Fumio Hasegawa,et al.  Stemness and anti‐cancer drug resistance in ATP‐binding cassette subfamily G member 2 highly expressed pancreatic cancer is induced in 3D culture conditions , 2018, Cancer science.

[9]  Hua Yu,et al.  JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance. , 2018, Cell metabolism.

[10]  M. Michishita,et al.  Electron microscopic analysis of different cell types in human pancreatic cancer spheres. , 2017, Oncology letters.

[11]  E. Chiricozzi,et al.  Gangliosides in Membrane Organization. , 2018, Progress in molecular biology and translational science.

[12]  Zack Z Wang,et al.  Epithelial–mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis , 2017, Journal of cellular physiology.

[13]  S. Mayor,et al.  The mystery of membrane organization: composition, regulation and roles of lipid rafts , 2017, Nature Reviews Molecular Cell Biology.

[14]  Hee-Jung Choi,et al.  The function of cancer-shed gangliosides in macrophage phenotype: involvement with angiogenesis , 2016, Oncotarget.

[15]  T. Ishiwata.  Cancer stem cells and epithelial‐mesenchymal transition: Novel therapeutic targets for cancer , 2016, Pathology international.

[16]  G. D’Angelo,et al.  Glycosphingolipid–Protein Interaction in Signal Transduction , 2016, International journal of molecular sciences.

[17]  K. Biswas,et al.  Ganglioside GM2 mediates migration of tumor cells by interacting with integrin and modulating the downstream signaling pathway. , 2016, Biochimica et biophysica acta.

[18]  A. Krasinskas,et al.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas , 2015, The American journal of surgical pathology.

[19]  Paul D. Smith,et al.  MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model , 2015, Molecular Cancer Therapeutics.

[20]  M. Toyoda,et al.  Ganglioside GM1 Contributes to the State of Insulin Resistance in Senescent Human Arterial Endothelial Cells , 2015, The Journal of Biological Chemistry.

[21]  D. Mahuran,et al.  Liquid chromatography/electrospray ionisation-tandem mass spectrometry quantification of GM2 gangliosides in human peripheral cells and plasma. , 2014, Analytical biochemistry.

[22]  Benjamin D. Smith,et al.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.

[23]  P. Delannoy,et al.  How Do Gangliosides Regulate RTKs Signaling? , 2013, Cells.

[24]  Yihui Liu,et al.  Tumor gangliosides accelerate murine tumor angiogenesis , 2013, Angiogenesis.

[25]  M. Toyoda,et al.  Glycoconjugates and Related Molecules in Human Vascular Endothelial Cells , 2013, International journal of vascular medicine.

[26]  K. Handa,et al.  Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells , 2013, Proceedings of the National Academy of Sciences.

[27]  B. Lupo,et al.  The Plasma Membrane Sialidase NEU3 Regulates the Malignancy of Renal Carcinoma Cells by Controlling β1 Integrin Internalization and Recycling* , 2012, The Journal of Biological Chemistry.

[28]  G. Hortobagyi,et al.  Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis. , 2012, The Journal of clinical investigation.

[29]  Y. Igarashi,et al.  Sphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-β by Microglia , 2012, The Journal of Biological Chemistry.

[30]  S. Akinaga,et al.  Genetically engineered humanized anti‐ganglioside GM2 antibody against multiple organ metastasis produced by GM2‐expressing small‐cell lung cancer cells , 2011, Cancer science.

[31]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[32]  M. Nowak,et al.  Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.

[33]  Kazuro Furukawa,et al.  GM1 / GD1b / GA1 synthase expression results in the reduced cancer phenotypes with modulation of composition and raft‐localization of gangliosides in a melanoma cell line , 2010, Cancer science.

[34]  J. M. Aerts,et al.  Inhibition of Glycosphingolipid Synthesis Induces a Profound Reduction of Plasma Cholesterol and Inhibits Atherosclerosis Development in APOE*3 Leiden and Low-Density Lipoprotein Receptor−/− Mice , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[35]  J. D'haese,et al.  Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. , 2009, Gastroenterology.

[36]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[37]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[38]  S. Hakomori,et al.  Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. , 2008, Biochimica et biophysica acta.

[39]  Seng H. Cheng,et al.  Inhibiting Glycosphingolipid Synthesis Improves Glycemic Control and Insulin Sensitivity in Animal Models of Type 2 Diabetes , 2007, Diabetes.

[40]  M. Borner,et al.  Successful challenge with the fully human EGFR antibody panitumumab following an infusion reaction with the chimeric EGFR antibody cetuximab. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[41]  S. O’Rahilly,et al.  Pharmacological Inhibition of Glucosylceramide Synthase Enhances Insulin Sensitivity , 2007, Diabetes.

[42]  Kazuro Furukawa,et al.  Overexpressed GM1 Suppresses Nerve Growth Factor (NGF) Signals by Modulating the Intracellular Localization of NGF Receptors and Membrane Fluidity in PC12 Cells* , 2004, Journal of Biological Chemistry.

[43]  C. Hollak,et al.  Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[44]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[45]  S. Hakomori.  Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. , 1996, Cancer research.

[46]  L. Old,et al.  Human monoclonal antibodies to glycolipids and other carbohydrate antigens: dissection of the humoral immune response in cancer patients. , 1989, Cancer research.

[47]  L. Ulsh,et al.  Immunosuppressive activity of human neuroblastoma tumor gangliosides , 1989, International journal of cancer.

[48]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[49]  S. Kitada,et al.  Gangliosides shed by tumor cells enhance tumor formation in mice. , 1987, The Journal of clinical investigation.

[50]  A. Dell,et al.  Glycosphingolipids of lectin-resistant mutants of the highly metastatic mouse tumor cell line, MDAY-D2. , 1987, Cancer research.

[51]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[52]  G. Zwingelstein,et al.  Studies of a ganglioside fraction extracted from human malignant melanoma. , 1976, Biochimie.